Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery

References

• Kaur IP, Smitha R, Aggarwal D, Kapil M. (2002). Acetazolamide: Future perspective in topical glaucoma therapeutics. Int J Pharm, 248:1–14.
   PubMed Web of Science ®Google Scholar
• Blomdahl S, Calissendorff BM, Tengrowth B, Wallin O. (1997). Blindness in glaucoma patients. Acta Ophthalmol, 75:589–91.
   Web of Science ®Google Scholar
• Munier A, Gunning T, Kenny D, O’Keefe M. (1998). Causes of blindness in the adult population of the Republic of Ireland. Br J Ophthalmol, 82:630–3.
   PubMed Web of Science ®Google Scholar
• Hoyng PF, van Beek LM. (2000). Pharmacological therapy for glaucoma: A review. Drugs, 59:411–34.
   Google Scholar
• Balfour JA, Wilde MI. (1997). Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension. Drugs Aging, 10:384–403.
   PubMed Web of Science ®Google Scholar
• Rusk C, Sharpe E, Laurence J, Polis A, Adamsons I. (1998). Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group. Clin Ther, 20:454–66.
   Google Scholar
• Silver LH. (2000). Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: Results from two multicenter comfort studies. Brinzolamide Comfort Study Group. Surv Ophthalmol, 44(Suppl. 2):S141–5.
   PubMedGoogle Scholar
• Afouna MI, Khedr A, Abdel-Naim AB, Al-Marzoqi A. (2010). Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits. J Pharm Sci, 99:119–27.
   PubMed Web of Science ®Google Scholar
• Hughes PM, Mitra AK. (1993). Overview of ocular drug delivery and iatrogenic ocular cytopathologies. In: Mitra AK, ed. Ophthalmic drug delivery systems. New York: Marcel Dekker, 1–27.
   Google Scholar
• Ma WD, Xu H, Wang C, Nie SF, Pan WS. (2008). Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system. Int J Pharm, 350:247–56.
   PubMed Web of Science ®Google Scholar
• Edsman K, Carlfors J, Petersson R. (1998). Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci, 6:105–12.
   PubMed Web of Science ®Google Scholar
• Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. (1998). Ophthalmic drug delivery systems-recent advances. Prog Retin Eye Res, 17:33–58.
   PubMed Web of Science ®Google Scholar
• Kim EY, Gao ZG, Park JS, Li H, Han K. (2002). rhEGF/HP-beta-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm, 233:159–67.
   PubMed Web of Science ®Google Scholar
• García-Celma MJ. (1997). Solubilization of drugs in microemulsions. In: Solans C, Kunieda H, eds. Industrial applications of microemulsions. New York: Marcel Dekker, 123–45.
   Google Scholar
• Silva-Cunha A, Fialho SL, Carneiro LB, Oréfice F. (2003). Microemulsões como veículos de drogas para administração ocular tópica. Arq Bras Oftalmol, 66:385–91.
   Google Scholar
• Vandamme TF. (2002). Microemulsions as ocular drug delivery systems: Recent developments and future challenges. Prog Retin Eye Res, 21:15–34.
   PubMed Web of Science ®Google Scholar
• Azeem A, Ahmad FJ, Khar RK, Talegaonkar S. (2009). Nanocarrier for the transdermal delivery of an antiparkinsonian drug. AAPS PharmSciTech, 10:1093–103.
   PubMed Web of Science ®Google Scholar
• Jain R, Patravale VB. (2009). Development and evaluation of nitrendipine nanoemulsion for intranasal delivery. J Biomed Nanotechnol, 5:62–8.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Ramadan W. (2010). Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloids Surf B Biointerfaces, 75:356–62.
   PubMed Web of Science ®Google Scholar
• Ammar HO, Salama HA, Ghorab M, Mahmoud AA. (2009). Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech, 10:808–19.
   PubMed Web of Science ®Google Scholar
• Garti N, Aserin A, Tiunova I, Fanun M. (2000). A DSC study of water behavior in water-in-oil microemulsions stabilized by sucrose esters and butanol. Colloids Surf A Physicochem Eng Asp, 170:1–18.
   Web of Science ®Google Scholar
• Moreno MA, Ballesteros MP, Frutos P. (2003). Lecithin-based oil-in-water microemulsions for parenteral use: Pseudoternary phase diagrams, characterization and toxicity studies. J Pharm Sci, 92:1428–37.
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. (2007). Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm, 66:227–43.
   PubMed Web of Science ®Google Scholar
• Pandit NK, Kisaka J. (1996). Loss of gelation ability of Pluronic® F127 in the presence of some salts. Int J Pharm, 145:129–36.
   Web of Science ®Google Scholar
• Bentley MV, Marchetti JM, Ricardo N, Ali-Abi Z, Collett JH. (1999). Influence of lecithin on some physical chemical properties of poloxamer gels: Rheological, microscopic and in vitro permeation studies. Int J Pharm, 193:49–55.
   PubMed Web of Science ®Google Scholar
• Zaki NM, Awad GA, Mortada ND, Abd Elhady SS. (2007). Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci, 32:296–307.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Suzuki S, Kawasaki N, Endo K, Takahashi A, Attwood D. (2001). In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int J Pharm, 229:29–36.
   PubMed Web of Science ®Google Scholar
• Wu C, Qi H, Chen W, Huang C, Su C, Li W, . (2007). Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi, 127:183–91.
   PubMed Web of Science ®Google Scholar
• Khan KA, Rhodes CT. (1972). Effect of compaction pressure on the dissolution efficiency of some direct compression systems. Pharm Acta Helv, 47:594–607.
   PubMedGoogle Scholar
• Baydoun L, Furrer P, Gurny R, Muller-Goymann CC. (2004). New surface-active polymers for ophthalmic formulations: Evaluation of ocular tolerance. Eur J Pharm Biopharm, 58:169–75.
   PubMed Web of Science ®Google Scholar
• Draize JH, Woodard G, Calvey HO. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther, 82:377–90.
   Web of Science ®Google Scholar
• Hou MJ, Shah DO. (1987). Effects of the molecular structure of the interface and continuous phase on solubilization of water in water/oil microemulsions. Langmuir, 3:1086–96.
   Web of Science ®Google Scholar
• Garti N, Aserin A, Ezrahi S, Wachtel E. (1995). Water solubilization and chain length compatibility in nonionic microemulsions. J Colloid Interface Sci, 169:428–36.
   Web of Science ®Google Scholar
• Modi A, Tayade P. (2007). A comparative solubility enhancement profile of valdecoxib with different solubilization approaches. Indian J Pharm Sci, 69:274–8.
   Google Scholar
• Shiao SY, Chhabra V, Patist A, Free ML, Huibers PDT, Gregory A, . (1998). Chain length compatibility effects in mixed surfactant systems for technological applications. Adv Colloid Interface Sci, 74:1–29.
   Web of Science ®Google Scholar
• Mathis GA. (1999). Clinical ophthalmic pharmacology and therapeutics: Ocular drug delivery. In: Gelatt KN, ed. Veterinary ophthalmology. Florida: Lippincott Williams & Wilkins, 291–7.
   Google Scholar
• Fialho SL, da Silva-Cunha A. (2004). New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Experiment Ophthalmol, 32:626–32.
   PubMed Web of Science ®Google Scholar
• USP30-NF25. (2007). Pharmaceutical dosage forms: Ophthalmic preparations. The United State Pharmacopeia, The National Formulary, USP30-NF 25.
   Google Scholar
• Ciba-Geigy. (1977). Wissenschaftliche Tabellen Geigy. 8th ed. Basel: Ciba-Geigy.
   Google Scholar
• Keipert S, Siebenbrodt I, Lüders F, Bornschein M. (1989). Mikroemulsionen und ihre. Potenzielle pharmazeutische Nutzung. Pharmazie, 44:433–44.
   PubMedGoogle Scholar
• Vadnere M, Amidon G, Lindenbaum S, Haslam JE. (1984). Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int J Pharm, 22:207–18.
   Web of Science ®Google Scholar
• Nijenhuis KT. (1997). Thermoreversible networks: Viscoelastic properties and structure of gels. Adv Polym Sci, 130:160–93.
   Google Scholar
• Zhou Z, Chu B. (1987). Anomalous association behavior of an ethylene oxide/propylene oxide ABA block copolymer in water. Macromolecules, 20:3089–91.
   Web of Science ®Google Scholar
• Zhou Z, Chu B. (1988). Anomalous micellization behavior and composition heterogeneity of a triblock ABA copolymer of (A) ethylene oxide and (B) propylene oxide in aqueous solution. Macromolecules, 21:2548–54.
   Web of Science ®Google Scholar
• Glatter O, Scherf O, Schillen K, Brown W. (1994). Characterization of a poly(ethylene oxide)-poly(propylene oxide) triblock copolymer (E027–P039–E027) in aqueous solution. Macromolecules, 27:6046–54.
   Web of Science ®Google Scholar
• Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T. (2007). Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv, 14:507–715.
   PubMed Web of Science ®Google Scholar
• Koffi AA, Agnely F, Besnard M, Kablan Brou J, Grossiord JL, Ponchel G. (2008). In vitro and in vivo characteristics of a thermogelling and bioadhesive delivery system intended for rectal administration of quinine in children. Eur J Pharm Biopharm, 69(1):167–75.
   PubMed Web of Science ®Google Scholar
• Dumortier G, Grossiod JL, Zuber M, Couarraze G, Chaumeil JC. (1991). Rheological study of a thermoreversible morphine gel. Drug Dev Ind Pharm, 17:1255–65.
   Web of Science ®Google Scholar
• Juhasz J, Lenaerts V, Raymond P, Ong H. (1989). Diffusion of rat atrial natriuretic factor in thermoreversible poloxamer gels. Biomaterials, 10:265–8.
   PubMed Web of Science ®Google Scholar
• Wei G, Xu H, Ding PT, Li SM, Zheng JM. (2002). Thermosetting gels with modulated gelation temperature for ophthalmic use: The rheological and gamma scintigraphic studies. J Control Release, 83:65–74.
   PubMed Web of Science ®Google Scholar
• Liu T, Chu B. (2000). Formation of homogeneous gel-like phases by mixed triblock copolymer micelles in aqueous solution: FCC to BCC phase transition. J Appl Cryst, 33:727–30.
   Web of Science ®Google Scholar
• Bohorquez M, Koch C, Trygstad T, Pandit N. (1999). A study of the temperature-dependent micellization of Pluronic F127. J Colloid Interface Sci, 216:34–40.
   PubMed Web of Science ®Google Scholar
• Qi H, Chen W, Huang C, Li L, Chen C, Li W, . (2007). Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm, 337:178–87.
   PubMed Web of Science ®Google Scholar
• Choi HK, Jung JH, Ryu JM, Yoon SJ, Oh YK, Kim CK. (1998). Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm, 165:33–44.
   Web of Science ®Google Scholar
• Hughes WFJ. (1948). The tolerance of rabbit cornea for various chemical substances. Bull Johns Hopkins Hosp, 82:338–49.
   PubMedGoogle Scholar
• Laillier J, Plazonnet B, Le Douarec JC. (1976). Evaluation of an objective method of studying eye irritation. Proc Eur Soc Toxicol, 17:336–50.
   Google Scholar
• Conquet P, Durand G, Laillier J, Plazonnet B. (1977). Evaluation of ocular eye irritation in the rabbit: Objective versus subjective assessment. Toxicol Appl Pharmacol, 39:129–39.
   PubMed Web of Science ®Google Scholar
• Kwon JW, Han YK, Lee WJ, Cho CS, Paik SJ, Cho DI, . (2005). Biocompatibility of poloxamer hydrogel as an injectable intraocular lens: A pilot study. J Cataract Refract Surg, 31: 607–13.
   PubMed Web of Science ®Google Scholar
• Tamilvanan S, Benita S. (2004). The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur J Pharm Biopharm, 58:357–68.
   PubMed Web of Science ®Google Scholar
• Roggeband R, York M, Pericoi M, Braun W. (2000). Eye irritation responses in rabbit and man after single applications of equal volumes of undiluted model liquid detergent products. Food Chem Toxicol, 38:727–34.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev, 45:89–121.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Smitha R. (2002). Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm, 28:353–69.
   PubMed Web of Science ®Google Scholar
• Calvo P, Alonso MJ, Vila-Jato J, Robinson JR. (1996). Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol, 48:1147–52.
   PubMed Web of Science ®Google Scholar